MariMed Inc. (MRMD)
OTCMKTS
· Delayed Price · Currency is USD
0.115
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
MariMed Revenue
MariMed had revenue of $40.59M in the quarter ending September 30, 2024, with 4.62% growth. This brings the company's revenue in the last twelve months to $157.86M, up 8.47% year-over-year. In the year 2023, MariMed had annual revenue of $148.60M with 10.89% growth.
Revenue (ttm)
157.86M
Revenue Growth
+8.47%
P/S Ratio
0.28
Revenue / Employee
231.47K
Employees
721
Market Cap
44.31M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
MariMed News
- 4 weeks ago - MariMed Commences Wholesale Operations in Missouri - GlobeNewsWire
- 6 weeks ago - Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? - Benzinga
- 6 weeks ago - Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? - Benzinga
- 2 months ago - MariMed Inc (MRMD) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Industry Challenges - GuruFocus
- 2 months ago - Q3 2024 MariMed Inc Earnings Call Transcript - GuruFocus
- 2 months ago - MariMed Inc. (MRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MariMed's Q3 Revenue Slightly Up YoY As Net Loss Improves, Revises Guidance - Benzinga
- 2 months ago - MariMed Inc Reports Q3 2024 Revenue of $40.6 Million, Narrowed Net Loss to $1.0 Million - GuruFocus